简介：目的探讨恙虫病合并肝损害的临床特点。方法选取集中收治的70例恙虫病患者，观察其症状和体征，并进行肝功能和肝脏超声检查。结果在70例患者中42例（60％）出现不同程度的肝脏损害，轻、中、重度损害者分别占81％、14％和5％。所有病人给予病原治疗和护肝治疗后痊愈。结论恙虫病并发肝损害为一过性病变，且病变较轻，愈后好。

简介：目的探讨Dieulafoy病的诊断与治疗。方法对近年来15例Dieulafoy病临床和内镜资料进行分析。结果内镜治疗7例，其中注射高渗盐水或硬化剂5例，射频治疗2例，均立即止血，其中l例再次出血死亡。手术7例，均治愈。结论内镜治疗是Dieulafoy病主要治疗方法，其中射频治疗效果尚属满意，但需进一步观察总结经验。手术治疗可彻底解决血管畸形问题，仍为重要治疗手段。

简介：关于肝病患者血小板数量减少及血小板体积变化的文献屡有报道。肝硬变患者血小板减少早已熟知,长期认为其与脾肿大伴机能亢进有关。但对乙型肝炎患者血小板上述参数的变化及其发生机理知之甚少。为了评诂乙型肝炎患者血小板数量与体积的变化及该类患者的凝血功能状况,采用全自动血球计数仪检测

简介：Ithasbeenfoundthatexpressionof15-lipoxygenasc-1(15-LOX-1)anditsmainproduct,13-C-hydroxyoctadecadienoicacid(13-S-HODE),aredecreasedinhumancolorectalandesophagealcancersandthatnonsteroidalanti-inflammatorydrugs(NSAIDs)cantherspeuticallyinduce15-LOC-1expressiontotriggerapoptosisinthosecancercellsindependentlyCOX-2.WefoundthataspecificCOX-2inhibitorSC-236similarlyinduceapoptosisingastriccancercells,althoughthemechanismsoftheseeffectsremaintobedefined.Inthepresentstudy,wetestedwhetherSC-236inducedapoptosisthroughup-regulationof15-LOX-1ingastriccancercells.Wefoundthat,(a)SC-236inhibitedgrowthofgastriccancercellsmainlybyapoptosisinduced;(b)SC-236induced15-LOX-1expressionandincreasedendogenous13-S-HODEproduct,insteadof15-S-HETEduringapoptosisingastriccancercellswithout15-LOX-1expressionbeforetreatmentbySC-236;(c)sc-236didn'teffectexpressionofCOX-1,COX-2,5-LOXand12-LOX;and(d)15-LOX-1inhibitionsuppressedSC-236inducedapoptosis.ThesefindingsdemonstratedthatSC-236inducedapoptosisingastriccancercellsviaup-regulationof25-LOX-1.Theyalsosupporttheconceptthatthelossoftheproapopoticroleof15-LOX-1inepithelialcancersisnotlimitedtohumancolorectalandesophagealcancers.

简介：1990-01／2004-12我们采用自行设计的多孔针实施肝脓肿穿刺、冲洗、注入抗生素治疗，全部治愈，未出现并发症，现将诊治与护理体会报告如下。

简介：AIM:Todeterminewhetherischemicpreconditioning(IP)affectsthedevelopmentofedematouscerulein-inducedpancreatitisandtoassesstheroleofcyclooxygenase-1(COX-1),COX-2,andheatshockprotein70(HSP70)inthisprocess.METHODS:InmaleWistarrats,IPwasperformedbydampingofceliacartery(twicefor5minat5-minintervals).ThirtyminutesafterIPorshamoperation,acutepancreatitiswasinducedbycerulein.ActivityofCOX-1orCOX-2wasinhibitedbyresveratrolorrofecoxib,respectively(10mg/kg).RESULTS:IPsignificantlyreducedpancreaticdamageincerulein-inducedpancreatitisasdemonstratedbytheimprovementofpancreashistology,reductioninserumlipaseandpoly-Cribonucleaseactivity,andserumconcentrationofpro-inflammatoryinterleukin(IL)-1β.Also,IPattenuatedthepancreatitis-evokedfallinpancreaticbloodflowandpancreaticDNAsynthesis.Serumlevelofanti-inflammatoryIL-10wasnotaffectedbyIP.Cerulein-inducedpancreatitisandIPincreasedthecontentofHSP70inthepancreas.MaximalincreaseinHSP70wasobservedwhenIPwascombinedwithcerulein-inducedpancreatitis.InhibitionofCOXs,especiallyCOX-2,reducedtheprotectiveeffectofIPinedematouspancreatitis.CONCLUSION:OurresultsindicatethatIPreducespancreaticdamageincerulein-inducedpancreatitisandthiseffect,atleastinpart,dependsontheactivityofCOXsandpancreaticproductionofHSP70.

简介：异位妊娠是常见的妇产科疾病，近年来我们用甲氨喋呤(MTX)配伍米非司酮(Mife)治疗未破裂异位妊娠42例，取得良好效果，现报道如下。

简介：目的探讨热休克蛋白70（HSP70）、p53和增殖细胞核抗原（PCNA）在肝细胞癌（HCC）组织中的表达及其意义。方法采用免疫组化法检测正常人、慢性乙型肝炎、肝硬化和HCC肝或癌组织HSP70、p53和PCNA的表达情况。结果HCC组织HSP70、p53和PCNA表达阳性率明显高于非癌组织（x1^2=27.16x2^2=67.6,x3^2=40.6,P〈0.01）;HSP70在正常人、慢性乙型肝炎、肝硬化和HCC中的表达逐步增强;HSP70和p53在分化较好的HCC中的阳性率明显低于分化不良者（x1^2=6.8,P1〈0.01x2^2=6.1,P2〈0.05）,而PCNA表达与HCC组织分化程度无关（x2=2.4,P〉0.05）;HSP70表达强度与p53和PCNA表达关系密切（x1^2=41.3,x2^2=41.4,P〈0.01）。结论HCC是HSP70高表达肿瘤。HSP70表达与p53和PCNA表达密切相关,因而在HCC发生和发展中起重要作用。

简介：2002—04／2005—12我们采用低分子肝素、丁咯地尔联用治疗短暂性脑缺血发作（TIA）病人疗效显著，现总结报告如下。

简介：AIM:Heatshockprotein(HSP)70isover-expressedinhumangastriccancerandplaysanimportantroleintheprogressionofthiscancer.WeinvestigatedtheeffectsofantisenseHSP70oligomeronhumangastriccancercelllineSGC-7901,anditspotentialroleingenetherapyforthiscancer.METHODS:HumangastriccancercelllineSGC-7901wastreatedinvitrowithvariousconcentrationsofantisenseHSP70oligonucleotidesatdifferentintervals.Growthinhibitionwasdeterminedaspercentagebytrypanbluedyeexclusiontest.ExtractedDNAwaselectrophoresedonagarosegel,anddistributionofcellcycleandkineticsofapoptosisinductionwereanalyzedbypropidiumiodideDNAincorporationusingflowcytometry,whichwasalsousedtodetecttheeffectsofantisenseoligomerpretreatmentonthesubsequentapoptosisinducedbyheatshockinSGC-7901cells.ProteinswereextractedforsimultaneousmeasurementofHSP70expressionlevelbySDS-PAGEWesternblotting.RESULTS:Thenumberofviablecellsdecreasedinadoseandtime-dependentmanner,andladder-likepatternsofDNAfragmentswereobservedinSGC-7901cellstreatedwithantisenseHSP70oligomersataconcentrationof10μmol/Lfor48hor8μmol/Lfor72h,whichwereconsistentwithinter-nucleosomalDNAfragmentation.Flowcytometricanalysisshowedadose-andtime-dependentincreaseinapoptoticratebyHSP70antisenseoligomers.ThisresponsewasaccompaniedwithadecreaseinthepercentageofcellsintheG1andSphasesofthecellcycle,suggestinginhibitionofcellproliferation.Inaddition,flowcytometryalsoshowedthatpretreatmentofSGC-7901cellswithHSP70antisenseoligomersenhancedthesubsequentapoptosisinducedbyheatshocktreatment.WesternblottingdemonstratedthatHSP70antisenseoligomersinhibitedHSP70expression,whichprecededapoptosis,andHSP70wasundetectableattheconcentrationof10μmol/Lfor48hor8μmol/Lfor72h.CONCLUSION:AntisenseHSP70oligomerscanabrogateHSP70expressioninSGC-7901cells,wh

简介：目的探讨联合应用埃索美拉唑镁、铝碳酸镁和伊托比利治疗胃食管反流病（gastroesophagealrefluxdisease,GERD）的临床疗效。方法将83例GERD病人随机分为A组和B组,分别采用埃索美拉唑镁、铝碳酸镁及伊托比利和奥美拉唑、铝碳酸镁及伊托比利治疗。3周后评价临床疗效,6周后评价胃镜下有效率。结果治疗3周后A组和B组病人临床症状总改善率分别是92.9%和73.2%,差异有统计学意义（P〈0.05）。治疗6周后A组和B组病人胃镜下有效率分别是97.6%和80.5%,差异有统计学意义（P〈0.05）。结论埃索美拉唑镁、铝碳酸镁和伊托比利治疗GERD优于奥美拉唑、铝碳酸镁及伊托比利。